APA

Lee K. C., Shorr R., Rodriguez R., Maturo C., Boteju L. W. & Sheldon A. (20111227). Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism. : Drug metabolism letters.

Chicago

Lee King C, Shorr Robert, Rodriguez Robert, Maturo Claudia, Boteju Lakmal W and Sheldon Adrian. 20111227. Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism. : Drug metabolism letters.

Harvard

Lee K. C., Shorr R., Rodriguez R., Maturo C., Boteju L. W. and Sheldon A. (20111227). Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism. : Drug metabolism letters.

MLA

Lee King C, Shorr Robert, Rodriguez Robert, Maturo Claudia, Boteju Lakmal W and Sheldon Adrian. Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism. : Drug metabolism letters. 20111227.